Ratings by Piper Sandler

Date Analyst CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/4/2021 David Amsellem Horizon Therapeutics HZNP Maintain Overweight
(N/A)
141.00
(125.00)
 
 
  Details
8/4/2021 Edward Tenthoff Alnylam Pharmaceuticals ALNY Downgrade Neutral
(Overweight)
181.00
(N/A)
177.96
(182.49)
2.55% Details
12,586 more...